Giorgio Scagliotti

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Novello Silvia; Falcone Alfredo; Crinò Lucio; Rinaldi Massimo; Nardi Mario; De Marinis Filippo; Tonato Maurizio; Tibaldi Carmelo; Tinazzi Angelo; Russo Francesca; Grassivaro Nicoletta; Scagliotti Giorgio Vittorio
Randomised multicenter phase II study of two schedules of docetaxel and gemcitabine or cisplatin/gemcitabine followed by docetaxel as first line treatment for advanced non-small cell lung cancer.
Ceppi Paolo; Papotti Mauro; Monica Valentina; Iacono Marco Lo; Saviozzi Silvia; Pautasso Marisa; Novello Silvia; Mussino Stefano; Bracco Enrico; Volante Marco; Scagliotti Giorgio V
Effects of Src kinase inhibition induced by dasatinib in non-small cell lung cancer cell lines treated with cisplatin.
Novello S; Scagliotti G V; Rosell R; Socinski M A; Brahmer J; Atkins J; Pallares C; Burgess R; Tye L; Selaru P; Wang E; Chao R; Govindan R
Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Giorgio Scagliotti (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Novello Silvia; Falcone Alfredo; Crinò Lucio; Rinaldi Massimo; Nardi Mario; De Marinis Filippo; Tonato Maurizio; Tibaldi Carmelo; Tinazzi Angelo; Russo Francesca; Grassivaro Nicoletta; Scagliotti Giorgio Vittorio
Randomised multicenter phase II study of two schedules of docetaxel and gemcitabine or cisplatin/gemcitabine followed by docetaxel as first line treatment for advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2009;66(3):327-32.
2009: Ceppi Paolo; Papotti Mauro; Monica Valentina; Iacono Marco Lo; Saviozzi Silvia; Pautasso Marisa; Novello Silvia; Mussino Stefano; Bracco Enrico; Volante Marco; Scagliotti Giorgio V
Effects of Src kinase inhibition induced by dasatinib in non-small cell lung cancer cell lines treated with cisplatin.
Molecular cancer therapeutics 2009;8(11):3066-74.
2009: Novello S; Scagliotti G V; Rosell R; Socinski M A; Brahmer J; Atkins J; Pallares C; Burgess R; Tye L; Selaru P; Wang E; Chao R; Govindan R
Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer.
British journal of cancer 2009;101(9):1543-8.
2009: Scagliotti Giorgio V; Park Keunchil; Patil Shekar; Rolski Janusz; Goksel Tuncay; Martins Renato; Gans Steven J M; Visseren-Grul Carla; Peterson Patrick
Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: a risk-benefit analysis of a large phase III study.
European journal of cancer (Oxford, England : 1990) 2009;45(13):2298-303.
2009: Cassoni Paola; Daniele Lorenzo; Maldi Elena; Righi Luisella; Tavaglione Veronica; Novello Silvia; Volante Marco; Scagliotti Giorgio Vittorio; Papotti Mauro
Caveolin-1 expression in lung carcinoma varies according to tumour histotype and is acquired de novo in brain metastases.
Histopathology 2009;55(1):20-7.
2009: Daniele Lorenzo; Cassoni Paola; Bacillo Elisa; Cappia Susanna; Righi Luisella; Volante Marco; Tondat Fabrizio; Inghirami Giorgio; Sapino Anna; Scagliotti Giorgio V; Papotti Mauro; Novello Silvia
Epidermal growth factor receptor gene in primary tumor and metastatic sites from non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(6):684-8.
2009: Monica Valentina; Ceppi Paolo; Righi Luisella; Tavaglione Veronica; Volante Marco; Pelosi Giuseppe; Scagliotti Giorgio V; Papotti Mauro
Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009;22(5):709-17.
2009: Saviozzi Silvia; Ceppi Paolo; Novello Silvia; Ghio Paolo; Lo Iacono Marco; Borasio Piero; Cambieri Alberto; Volante Marco; Papotti Mauro; Calogero Raffaele A; Scagliotti Giorgio V
Non-small cell lung cancer exhibits transcript overexpression of genes associated with homologous recombination and DNA replication pathways.
Cancer research 2009;69(8):3390-6.
2009: Scagliotti Giorgio V; Longo Marina; Novello Silvia
Nonsmall cell lung cancer in never smokers.
Current opinion in oncology 2009;21(2):99-104.
2009: Scagliotti Giorgio V; Ceppi Paolo; Capelletto Enrica; Novello Silvia
Updated clinical information on multitargeted antifolates in lung cancer.
Clinical lung cancer 2009;10 Suppl 1():S35-40.
2009: Scagliotti Giorgio; Hanna Nasser; Fossella Frank; Sugarman Katherine; Blatter Johannes; Peterson Patrick; Simms Lorinda; Shepherd Frances A
The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies.
The oncologist 2009;14(3):253-63.
2008: Früh Martin; Rolland Estelle; Pignon Jean-Pierre; Seymour Lesley; Ding Keyue; Tribodet Hélène; Winton Timothy; Le Chevalier Thierry; Scagliotti Giorgio V; Douillard Jean Yves; Spiro Stephen; Shepherd Frances A
Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(21):3573-81.
2008: Taylor Paul; Castagneto Bruno; Dark Graham; Marangolo Maurizio; Scagliotti Giorgio V; van Klaveren Rob J; Labianca Roberto; Serke Monika; Schuette W; van Meerbeeck Jan P; Heigener David; Liu Yushan; Adachi Susumu; Blatter Johannes; von Pawel Joachim
Single-agent pemetrexed for chemonaïve and pretreated patients with malignant pleural mesothelioma: results of an International Expanded Access Program.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(7):764-71.
2008: Cappia Susanna; Righi Luisella; Mirabelli Dario; Ceppi Paolo; Bacillo Elisa; Ardissone Francesco; Molinaro Luca; Scagliotti Giorgio V; Papotti Mauro
Prognostic role of osteopontin expression in malignant pleural mesothelioma.
American journal of clinical pathology 2008;130(1):58-64.
2008: Pignon Jean-Pierre; Tribodet Hélène; Scagliotti Giorgio V; Douillard Jean-Yves; Shepherd Frances A; Stephens Richard J; Dunant Ariane; Torri Valter; Rosell Rafael; Seymour Lesley; Spiro Stephen G; Rolland Estelle; Fossati Roldano; Aubert Delphine; Ding Keyue; Waller David; Le Chevalier Thierry;
Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(21):3552-9.
2008: Scagliotti Giorgio Vittorio; Parikh Purvish; von Pawel Joachim; Biesma Bonne; Vansteenkiste Johan; Manegold Christian; Serwatowski Piotr; Gatzemeier Ulrich; Digumarti Raghunadharao; Zukin Mauro; Lee Jin S; Mellemgaard Anders; Park Keunchil; Patil Shehkar; Rolski Janusz; Goksel Tuncay; de Marinis Filippo; Simms Lorinda; Sugarman Katherine P; Gandara David
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(21):3543-51.
2008: Ceppi Paolo; Longo Marina; Volante Marco; Novello Silvia; Cappia Susanna; Bacillo Elisa; Selvaggi Giovanni; Saviozzi Silvia; Calogero Raffaele; Papotti Mauro; Scagliotti Giorgio V
Excision repair cross complementing-1 and topoisomerase IIalpha gene expression in small-cell lung cancer patients treated with platinum and etoposide: a retrospective study.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(6):583-9.
2008: Ceppi Paolo; Volante Marco; Ferrero Anna; Righi Luisella; Rapa Ida; Rosas Rosj; Berruti Alfredo; Dogliotti Luigi; Scagliotti Giorgio V; Papotti Mauro
Thymidylate synthase expression in gastroenteropancreatic and pulmonary neuroendocrine tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(4):1059-64.
2008: Socinski Mark A; Novello Silvia; Brahmer Julie R; Rosell Rafael; Sanchez Jose M; Belani Chandra P; Govindan Ramaswamy; Atkins James N; Gillenwater Heidi H; Pallares Cinta; Tye Lesley; Selaru Paulina; Chao Richard C; Scagliotti Giorgio V
Multicenter, phase II trial of sunitinib in previously treated, advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(4):650-6.
2008: Scagliotti Giorgio Vittorio; Selvaggi Giovanni
New data integrating multitargeted antifolates into treatment of first-line and relapsed non-small-cell lung cancer.
Clinical lung cancer 2008;9 Suppl 3():S122-8.
2007: Scagliotti G V
Potential role of multi-targeted tyrosine kinase inhibitors in non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18 Suppl 10():x32-41.
2007: Volante Marco; Saviozzi Silvia; Rapa Ida; Ceppi Paolo; Cappia Susanna; Calogero Raffaele; Novello Silvia; Borasio Piero; Papotti Mauro; Scagliotti Giorgio V
Epidermal growth factor ligand/receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer.
Cancer 2007;110(6):1321-8.
2007: Marci Valerio; Volante Marco; Cappia Susanna; Righi Luisella; Novello Corrado; Scagliotti Giorgio V; Brambilla Elisabeth; Papotti Mauro
Basaloid adenocarcinoma. A new variant of pulmonary adenocarcinoma.
Virchows Archiv : an international journal of pathology 2007;451(3):729-36.
2007: Scagliotti Giorgio
Multimodality approach to early-stage non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2007;57 Suppl 2():S6-11.
2007: Righi Luisella; Volante Marco; Rapa Ida; Scagliotti Giorgio V; Papotti Mauro
Neuro-endocrine tumours of the lung. A review of relevant pathological and molecular data.
Virchows Archiv : an international journal of pathology 2007;451 Suppl 1():S51-9.
2007: Scagliotti Giorgio
Optimizing chemotherapy for patients with advanced non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2 Suppl 2():S86-91.
2007: Giachino Daniela F; Ghio Paolo; Regazzoni Silvia; Mandrile Giorgia; Novello Silvia; Selvaggi Giovanni; Gregori Dario; DeMarchi Mario; Scagliotti Giorgio V
Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(10):2876-81.
2007: Novello S; Bruzzi P; Barone C; Buosi R; Masotti A; Michetti G; Fioretti M; Barbera S; Spatafora M; Garetto L; Mazzanti P; Dongiovanni V; Selvaggi G; Crinò L; Scagliotti G V
Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(5):903-8.
2007: Scagliotti Giorgio Vittorio; Selvaggi Giovanni
Emerging drugs for mesothelioma.
Expert opinion on emerging drugs 2007;12(1):127-37.
2007: Araújo António; Ribeiro Ricardo; Azevedo Isabel; Coelho Ana; Soares Marta; Sousa Berta; Pinto Daniela; Lopes Carlos; Medeiros Rui; Scagliotti Giorgio V
Genetic polymorphisms of the epidermal growth factor and related receptor in non-small cell lung cancer--a review of the literature.
The oncologist 2007;12(2):201-10.
2007: Gelormino Elena; Pagano Eva; Appiano Silvana; Ceccarelli Manuela; Ciuffreda Libero; Comandone Alessandro; Farina Enzo; Merletti Franco; Mussa Antonio; Penna Angelo; Ponti Antonio; Raciti Ida; Scagliotti Giorgio Vittorio; Segnan Nereo; Senore Carlo; Sismondi Piero; Vineis Paolo; Bertetto Oscar; Ciccone Giovannino
[Adapting clinical practice guidelines to a regional oncology network: the Piedmont experience]
Epidemiologia e prevenzione 2007;31(1):25-33.
2007: Zecchina Gabriella; Ghio Paolo; Bosio Sandra; Cravino Marta; Camaschella Clara; Scagliotti Giorgio V
Reactive thrombocytosis might contribute to chemotherapy-related thrombophilia in patients with lung cancer.
Clinical lung cancer 2007;8(4):264-7.
2006: Ceppi P; Volante M; Novello S; Rapa I; Danenberg K D; Danenberg P V; Cambieri A; Selvaggi G; Saviozzi S; Calogero R; Papotti M; Scagliotti G V
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(12):1818-25.
2006: Kris Mark G; Giaccone Giuseppe; Davies Angela; Fukuoka Masahiro; Garfield David H; Jassem Jacek; Quoix Elisabeth A; Sandler Alan B; Scagliotti Giorgio V; Van Meerbeeck Jan P; West Howard
Systemic therapy of bronchioloalveolar carcinoma: results of the first IASLC/ASCO consensus conference on bronchioloalveolar carcinoma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(9 Suppl):S32-6.
2006: Papotti Mauro; Kalebic Thea; Volante Marco; Chiusa Luigi; Bacillo Elisa; Cappia Susanna; Lausi Paolo; Novello Silvia; Borasio Piero; Scagliotti Giorgio V
Bone sialoprotein is predictive of bone metastases in resectable non-small-cell lung cancer: a retrospective case-control study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(30):4818-24.
2006: Ceppi Paolo; Volante Marco; Saviozzi Silvia; Rapa Ida; Novello Silvia; Cambieri Alberto; Lo Iacono Marco; Cappia Susanna; Papotti Mauro; Scagliotti Giorgio V
Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase.
Cancer 2006;107(7):1589-96.
2006: Scagliotti Giorgio V
Can advanced non-small-cell lung cancer be treated with weekly instead of 3-weekly docetaxel?
Nature clinical practice. Oncology 2006;3(6):294-5.
2006: Rapa Ida; Volante Marco; Cappia Susanna; Rosas Rosj; Scagliotti Giorgio V; Papotti Mauro
Cathepsin K is selectively expressed in the stroma of lung adenocarcinoma but not in bronchioloalveolar carcinoma. A useful marker of invasive growth.
American journal of clinical pathology 2006;125(6):847-54.
2006: Cappuzzo F; Novello S; De Marinis F; Selvaggi G; Scagliotti G V; Barbieri F; Maur M; Papi M; Pasquini E; Bartolini S; Marini L; Crinò L
A randomized phase II trial evaluating standard (50 mg/min) versus low (10 mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapy.
Lung cancer (Amsterdam, Netherlands) 2006;52(3):319-25.
2006: Scagliotti Giorgio
Proteasome inhibitors in lung cancer.
Critical reviews in oncology/hematology 2006;58(3):177-89.
2006: Scagliotti G V; Novello S
Current status of adjuvant chemotherapy in NSCLC.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 5():v62-3.
2006: Ghio Paulo; Cappia Susanna; Selvaggi Giovanni; Novello Sylvia; Lausi Paulo; Zecchina Gabriella; Papotti Marno; Borasio Piero; Scagliotti Giorgio V
Prognostic role of protease-activated receptors 1 and 4 in resected stage IB non-small-cell lung cancer.
Clinical lung cancer 2006;7(6):395-400.
2006: Scagliotti Giorgio V; Novello Silvia
The way forward: new drugs and new therapeutic strategies in lung cancer therapy.
Clinical lung cancer 2006;7 Suppl 4():S109-10.
2006: Scagliotti G V; Szczesna A; Ramlau R; Cardenal F; Mattson K; Van Zandwijk N; Price A; Lebeau B; Debus J; Manegold C
Docetaxel-based induction therapy prior to radiotherapy with or without docetaxel for non-small-cell lung cancer.
British journal of cancer 2006;94(10):1375-82.
2006: Bovio S; Cataldi A; Reimondo G; Sperone P; Novello S; Berruti A; Borasio P; Fava C; Dogliotti L; Scagliotti G V; Angeli A; Terzolo M
Prevalence of adrenal incidentaloma in a contemporary computerized tomography series.
Journal of endocrinological investigation 2006;29(4):298-302.
2006: Saviozzi Silvia; Cordero Francesca; Lo Iacono Marco; Novello Silvia; Scagliotti Giorgio V; Calogero Raffaele A
Selection of suitable reference genes for accurate normalization of gene expression profile studies in non-small cell lung cancer.
BMC cancer 2006;6():200.
2005: Scagliotti Giorgio
An evaluation of pemetrexed in second-line treatment of non-small cell lung cancer.
Expert opinion on pharmacotherapy 2005;6(16):2855-66.
2005: Selvaggi Giovanni; Scagliotti Giorgio V
Management of bone metastases in cancer: a review.
Critical reviews in oncology/hematology 2005;56(3):365-78.
2005: Cardinale Luciano; Cortese Giancarlo; Borasio Piero; Dogliotti Luigi; Ferraris Fabrizio; Novello Silvia; Perotto Fabio; Scagliotti Giorgio; Fava Cesare
Low dose CT in early lung cancer diagnosis: Prevalence data.
La Radiologia medica 2005;110(5-6):532-43.
2005: Scagliotti G V
Pemetrexed: a new cytotoxic agent in the development for first-line non-small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2005;50 Suppl 1():S18-9.
2005: Scagliotti Giorgio V; Smit Egbert; Bosquee Lionel; O'Brien Mary; Ardizzoni Andrea; Zatloukal Peter; Eberhardt Wilfried; Smid-Geirnaerdt Maartje; de Bruin Hein G; Dussenne Sonia; Legrand Catherine; Giaccone Giuseppe;
A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956).
Lung cancer (Amsterdam, Netherlands) 2005;50(1):91-6.
2005: Novello S; Fava C; Borasio P; Dogliotti L; Cortese G; Crida B; Selvaggi G; Lausi P; Brizzi M P; Sperone P; Cardinale L; Ferraris F; Perotto F; Priola A; Scagliotti G V
Three-year findings of an early lung cancer detection feasibility study with low-dose spiral computed tomography in heavy smokers.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(10):1662-6.
2005: Scagliotti Giorgio V
The ALPI Trial: the Italian/European experience with adjuvant chemotherapy in resectable non-small lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13 Pt 2):5011s-5016s.
2005: Lynch Thomas J; Bogart Jeffrey A; Curran Walter J; DeCamp Malcolm M; Gandara David R; Goss Glenwood; Henschke Claudia I; Jett James R; Johnson Bruce E; Kelly Karen L; Le Chevalier Thierry; Mulshine James L; Scagliotti Giorgio V; Schiller Joan H; Shaw Alice; Thatcher Nick; Vokes Everett E; Wood Douglas E; Hart Carol
Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13 Pt 2):4981s-4983s.
2005: Cappuzzo F; Novello S; De Marinis F; Franciosi V; Maur M; Ceribelli A; Lorusso V; Barbieri F; Castaldini L; Crucitta E; Marini L; Bartolini S; Scagliotti G V; Crinò L
Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer.
British journal of cancer 2005;93(1):29-34.
2005: Novello S; Kielhorn A; Stynes G; Selvaggi G; De Marinis F; Maestri A; Foggi P; Tilden D; Tonato M; Crinò L; Rinaldi M; Migliorino A M; Scagliotti G V;
Cost-minimisation analysis comparing gemcitabine/cisplatin, paclitaxel/carboplatin and vinorelbine/cisplatin in the treatment of advanced non-small cell lung cancer in Italy.
Lung cancer (Amsterdam, Netherlands) 2005;48(3):379-87.
2005: Scagliotti Giorgio V
Which should be added to cisplatin for advanced non-small-cell lung cancer--vinorelbine or gemcitabine?
Nature clinical practice. Oncology 2005;2(4):190-1.
2005: Scagliotti Giorgio V
Pemetrexed plus carboplatin or oxaliplatin in advanced non-small cell lung cancer.
Seminars in oncology 2005;32(2 Suppl 2):S5-8.
2005: Le Chevalier Thierry; Arriagada Rodrigo; Pignon Jean-Pierre; Scagliotti Giorgio V
Should adjuvant chemotherapy become standard treatment in all patients with resected non-small-cell lung cancer?
The lancet oncology 2005;6(3):182-4.
2005: Scagliotti Giorgio V; Kortsik Cornelius; Dark Graham G; Price Allan; Manegold Christian; Rosell Rafael; O'Brien Mary; Peterson Patrick M; Castellano Daniel; Selvaggi Giovanni; Novello Silvia; Blatter Johannes; Kayitalire Louis; Crino Lucio; Paz-Ares Luis
Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer: a multicenter, randomized, phase II trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(2 Pt 1):690-6.
2005: Le Chevalier T; Scagliotti G; Natale R; Danson S; Rosell R; Stahel R; Thomas P; Rudd R M; Vansteenkiste J; Thatcher N; Manegold C; Pujol J-L; van Zandwijk N; Gridelli C; van Meerbeeck J P; Crino L; Brown A; Fitzgerald P; Aristides M; Schiller J H
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes.
Lung cancer (Amsterdam, Netherlands) 2005;47(1):69-80.
2005: Scagliotti G V; Novello S
State of the art in mesothelioma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 2():ii240-5.
2004: Scagliotti Giorgio V; Douillard J-Y
Docetaxel in combined-modality treatment of inoperable locally or regionally advanced lung cancer.
Lung cancer (Amsterdam, Netherlands) 2004;46 Suppl 2():S13-21.
2004: Scagliotti Giorgio V; Novello Silvia
Current development of adjuvant treatment of non-small-cell lung cancer.
Clinical lung cancer 2004;6 Suppl 2():S63-70.
2004: Scagliotti Giorgio V; Novello Silvia; Crino Lucio; Rosell Rafael
Pemetrexed in front-line chemotherapy for advanced non-small-cell lung cancer.
Oncology (Williston Park, N.Y.) 2004;18(13 Suppl 8):32-7.
2004: Scagliotti Giorgio V; Selvaggi Giovanni; Novello Silvia; Hirsch Fred R
The biology of epidermal growth factor receptor in lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(12 Pt 2):4227s-4232s.
2004: Lynch Thomas J; Adjei Alex A; Bunn Paul A; DuBois Raymond N; Gandara David R; Giaccone Giuseppe; Govindan Ramaswamy; Herbst Roy S; Johnson Bruce E; Khuri Fadlo R; Perez-Soler Roman; Rosell Rafael; Rowinsky Eric K; Sandler Alan B; Scagliotti Giorgio V; Schiller Joan H; Shapiro Geoffrey I; Socinski Mark A; Hart Carol S
Novel agents in the treatment of lung cancer: conference summary statement.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(12 Pt 2):4199s-4204s.
2004: Herbst Roy S; Giaccone Giuseppe; Schiller Joan H; Natale Ronald B; Miller Vincent; Manegold Christian; Scagliotti Giorgio; Rosell Rafael; Oliff Ira; Reeves James A; Wolf Michael K; Krebs Annetta D; Averbuch Steven D; Ochs Judith S; Grous John; Fandi Abderrahim; Johnson David H
Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 2.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(5):785-94.
2004: Giaccone Giuseppe; Herbst Roy S; Manegold Christian; Scagliotti Giorgio; Rosell Rafael; Miller Vincent; Natale Ronald B; Schiller Joan H; Von Pawel Joachim; Pluzanska Anna; Gatzemeier Ulrich; Grous John; Ochs Judith S; Averbuch Steven D; Wolf Michael K; Rennie Pamela; Fandi Abderrahim; Johnson David H
Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 1.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(5):777-84.
2004: Selvaggi G; Novello S; Torri V; Leonardo E; De Giuli P; Borasio P; Mossetti C; Ardissone F; Lausi P; Scagliotti G V
Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(1):28-32.
2003: Postmus Pieter E; Rocmans Pierre; Asamura Hisao; Ball David; Belderbos José; Cappello Matteo; Jassem Jacek; Novello Silvia; Pass Harvey; Passlick Bernward; Pirker Robert; Ready Neal; Sause William; Scagliotti Giorgio; Vansteenkiste Johan; Westeel Virginie; van Zandwijk Nico
Consensus report IASLC workshop Bruges, September 2002: pretreatment minimal staging for non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2003;42 Suppl 1():S3-6.
2003: Scagliotti Giorgio; Novello Silvia
Adjuvant chemotherapy after complete resection for early stage NSCLC.
Lung cancer (Amsterdam, Netherlands) 2003;42 Suppl 1():S47-51.
2003: Scagliotti Giorgio V; Fossati Roldano; Torri Valter; Crinò Lucio; Giaccone Giuseppe; Silvano Giovanni; Martelli Massimo; Clerici Maurizia; Cognetti Francesco; Tonato Maurizio;
Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer.
Journal of the National Cancer Institute 2003;95(19):1453-61.
2003: Rosell Rafael; Crino Lucio; Danenberg Kathleen; Scagliotti Giorgio; Bepler Gerold; Taron Miquel; Alberola Vicente; Provencio Mariano; Camps Carlos; De Marinis Filippo; Sanchez Jose Javier; Peñas Ramon
Targeted therapy in combination with gemcitabine in non-small cell lung cancer.
Seminars in oncology 2003;30(4 Suppl 10):19-25.
2003: Scagliotti Giorgio V; Novello Silvia
Efficacy of neoadjuvant strategies with gemcitabine and other chemotherapy in resectable non-small cell lung cancer: a combined modality approach.
Seminars in oncology 2003;30(4 Suppl 10):13-8.
2003: Bunn Paul A; Shepherd Frances A; Sandler Alan; Le Chevalier Thierry; Belani Chandra P; Kosmidis Paris A; Scagliotti Giorgio V; Giaccone Giuseppe
Ongoing and future trials of biologic therapies in lung cancer.
Lung cancer (Amsterdam, Netherlands) 2003;41 Suppl 1():S175-86.
2003: Hirsch Fred R; Scagliotti Giorgio V; Langer Corey J; Varella-Garcia Marileila; Franklin Wilbur A
Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies.
Lung cancer (Amsterdam, Netherlands) 2003;41 Suppl 1():S29-42.
2003: Rosell Rafael; Taron Miguel; Barnadas Agusti; Scagliotti Giorgio; Sarries Carme; Roig Barbara
Nucleotide excision repair pathways involved in Cisplatin resistance in non-small-cell lung cancer.
Cancer control : journal of the Moffitt Cancer Center 2003;10(4):297-305.
2003: Cappuzzo Federico; Selvaggi Giovanni; Gregorc Vanesa; Mazzoni Francesca; Betti Maura; Rita Migliorino Maria; Novello Silvia; Maestri Antonio; De Marinis Filippo; Darwish Samir; De Angelis Verena; Nelli Fabrizio; Bartolini Stefania; Scagliotti Giorgio V; Tonato Maurizio; Crinò Lucio
Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB nonsmall cell lung carcinoma: an Italian Lung Cancer Project Observational Study.
Cancer 2003;98(1):128-34.
2003: Scagliotti Giorgio V; Novello Silvia
Adjuvant therapy in completely resected non-small-cell lung cancer.
Current oncology reports 2003;5(4):318-25.
2003: Rosell Rafael; Scagliotti Giorgio; Danenberg Kathleen D; Lord Reginald V N; Bepler Gerold; Novello Silvia; Cooc Janine; Crinò Lucio; Sánchez José Javier; Taron Miquel; Boni Corrado; De Marinis Filippo; Tonato Maurizio; Marangolo Maurizio; Gozzelino Felice; Di Costanzo Franceso; Rinaldi Massimo; Salonga Dennis; Stephens Craig
Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer.
Oncogene 2003;22(23):3548-53.
2003: Scagliotti Giorgio V; Novello Silvia
Pemetrexed and its emerging role in the treatment of thoracic malignancies.
Expert opinion on investigational drugs 2003;12(5):853-63.
2003: Scagliotti Giorgio V; Novello Silvia
The dream is almost over...don't worry, look ahead.
Lung cancer (Amsterdam, Netherlands) 2003;40(2):187-90.
2003: Scagliotti Giorgio V; Shin Dong-M; Kindler Hedy L; Vasconcelles Michael J; Keppler Uwe; Manegold Christian; Burris Howard; Gatzemeier Ulrich; Blatter Johannes; Symanowski James T; Rusthoven James J
Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(8):1556-61.
2003: Scagliotti Giorgio V; Turrisi Andrew T
Docetaxel-based combined-modality chemoradiotherapy for locally advanced non-small cell lung cancer.
The oncologist 2003;8(4):361-74.
2002: Scagliotti Giorgio
Consensus development conference on the medical treatment of non-small cell lung cancer: treatment of the early stages.
Lung cancer (Amsterdam, Netherlands) 2002;38 Suppl 3():S23-9.
2002: Sarries Carme; Haura Eric B; Roig Barbara; Taron Miquel; Abad Albert; Scagliotti Giorgio; Rosell Rafael
Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer.
Pharmacogenomics 2002;3(6):763-80.
2002: Scagliotti Giorgio Vittorio; Novello Silvia
Gemcitabine (Gemzar)-based induction chemotherapy in non-small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2002;38 Suppl 2():S13-9.
2002: Scagliotti G V; De Marinis F; Rinaldi M; Crinò L; Gridelli C; Ricci S; Matano E; Boni C; Marangolo M; Failla G; Altavilla G; Adamo V; Ceribelli A; Clerici M; Di Costanzo F; Frontini L; Tonato M;
Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(21):4285-91.
2002: Scagliotti Giorgio Vittorio
Tyrosine kinase signal transduction inhibitors. Clinical trials.
I supplementi di Tumori : official journal of Società italiana di cancerologia ... [et al.] 2002;1(4):S34-6.
2002: Selvaggi Giovanni; Scagliotti Giorgio V; Torri Valter; Novello Silvia; Leonardo Eugenio; Cappia Susanna; Mossetti Claudio; Ardissone Francesco; Lausi Paolo; Borasio Piero
HER-2/neu overexpression in patients with radically resected nonsmall cell lung carcinoma. Impact on long-term survival.
Cancer 2002;94(10):2669-74.
2001: Scagliotti G V; Novello S
Role of erythropoietin in the treatment of lung cancer associated anaemia.
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 4():S91-4.
2001: Novello S; Galli L; Antonuzzo A; Crinó L; Pozzi E; Selvaggi G; Ricci S; Marrocolo F; Darwish S; Sorbolini S; Tonato M; Scagliotti G V
Phase II study of high-dose paclitaxel and carboplatin in previously untreated, unresectable non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2001;34(2):261-9.
2001: Dingemans A C; van Ark-Otte J; Span S; Scagliotti G V; van der Valk P; Postmus P E; Giaccone G
Topoisomerase IIalpha and other drug resistance markers in advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2001;32(2):117-28.
2000: Rinaldi M; Crinò L; Scagliotti G V; Mosconi A M; De Marinis F; Gridelli C; Selvaggi G; Della Giulia M; Darwish S; Porrozzi S; Novello S; Cipri A; Bartolucci R; Calandri C; Tonato M
A three-week schedule of gemcitabine-cisplatin in advanced non-small-cell lung cancer with two different cisplatin dose levels: a phase II randomized trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(10):1295-300.
2000: Scagliotti G V
Gemcitabine/cisplatin as induction therapy for stage IIIA N2 non-small-cell lung cancer.
Oncology (Williston Park, N.Y.) 2000;14(7 Suppl 4):15-9.
1999: Crinò L; Scagliotti G V; Ricci S; De Marinis F; Rinaldi M; Gridelli C; Ceribelli A; Bianco R; Marangolo M; Di Costanzo F; Sassi M; Barni S; Ravaioli A; Adamo V; Portalone L; Cruciani G; Masotti A; Ferrara G; Gozzelino F; Tonato M
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(11):3522-30.
1999: Crinò L; Mosconi A M; Scagliotti G; Selvaggi G; Novello S; Rinaldi M; Della Giulia M; Gridelli C; Rossi A; Calandri C; De Marinis F; Noseda M; Tonato M
Gemcitabine as second-line treatment for advanced non-small-cell lung cancer: A phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(7):2081-5.
1999: Scagliotti G V; Crinó L; Pozzi E; Corgna E; Selvaggi G; Novello S; Salsano G; Gentile A; Palladino M; Marracolo F; Tonato M
Phase I/II dose finding study of paclitaxel and carboplatin in advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1999;25(1):39-46.
1999: Scagliotti G V; Novello S; Selvaggi G
Multidrug resistance in non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10 Suppl 5():S83-6.
1998: Crinò L; Mosconi A M; Scagliotti G V; Selvaggi G; Rinaldi M; Della Giulia M; Gridelli C; Calandri C; De Marinis F; Noseda M; Tonato M
Gemcitabine as second-line treatment for relapsing or refractory advanced non-small cell lung cancer: a phase II trial.
Seminars in oncology 1998;25(4 Suppl 9):23-6.
1998: Giaccone G; Splinter T A; Debruyne C; Kho G S; Lianes P; van Zandwijk N; Pennucci M C; Scagliotti G; van Meerbeeck J; van Hoesel Q; Curran D; Sahmoud T; Postmus P E
Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2133-41.
1997: Scagliotti G V; Ferrari G; Novello S
Neo-adjuvant chemotherapy prior to surgery in stage III non-small cell lung cancer.
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Università di Napoli, Secondo ateneo 1997;52(6):531-4.
1997: Scagliotti G V; Crinò L
Chemotherapy of non-small cell lung cancer.
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Università di Napoli, Secondo ateneo 1997;52(3):287-95.
1997: Giaccone G; Postmus P E; Splinter T A; Diaz-Puente M; Van Zandwijk N; Scagliotti G; Ardizzoni A; Van Meerbeeck J; Debruyne C
Cisplatin/paclitaxel vs cisplatin/teniposide for advanced non-small-cell lung cancer. The EORTC Lung Cancer Cooperative Group. The European Organization for Research and Treatment of Cancer.
Oncology (Williston Park, N.Y.) 1997;11(4 Suppl 3):11-4.
1997: Crinò L; Scagliotti G; Marangolo M; Figoli F; Clerici M; De Marinis F; Salvati F; Cruciani G; Dogliotti L; Pucci F; Paccagnella A; Adamo V; Altavilla G; Incoronato P; Trippetti M; Mosconi A M; Santucci A; Sorbolini S; Oliva C; Tonato M
Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(1):297-303.
1996: Scagliotti G V; Crinó L; Pozzi E; Corgna E; Palladino M; Masiero P; Salsano V; Gentile A; Tonato M
Preliminary results of a dose-finding study of paclitaxel and carboplatin in patients with advanced non-small cell lung cancer.
Seminars in oncology 1996;23(6 Suppl 16):80-3.
1996: Postmus P E; Scagliotti G; Groen H J; Gozzelino F; Burghouts J T; Curran D; Sahmoud T; Kirkpatrick A; Giaccone G; Splinter T A
Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: an EORTC Phase III trial.
European journal of cancer (Oxford, England : 1990) 1996;32A(9):1498-503.
1996: Scagliotti G V; Ricardi U; Crinó L; Maranzano E; De Marinis F; Morandi M G; Meacci L; Marangolo M; Emiliani E; Rosti G; Figoli F; Bolzicco G; Masiero P; Gentile A; Tonato M
Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer.
Cancer chemotherapy and pharmacology 1996;38(6):561-5.
1995: Giaccone G; van Ark-Otte J; Scagliotti G; Capranico G; van der Valk P; Rubio G; Dalesio O; Lopez R; Zunino F; Walboomers J
Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lung.
Biochimica et biophysica acta 1995;1264(3):337-46.
1995: Gatti E; Scagliotti G V; Ferrari G; Mutti L; Pozzi E; Stacchini A; Fubini L; Aglietta M
Blood cell redistribution in the lung after administration of recombinant human granulocyte-macrophage colony-stimulating factor.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1995;8(9):1566-71.
1995: Stacchini A; Fubini L; Gatti E; Mutti L; Piacibello W; Sanavio F; Scagliotti G; Pozzi E; Aglietta M
In vivo effect of human granulocyte-macrophage colony-stimulating factor (GM-CSF) on neutrophil GM-CSF receptors.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(4):665-70.
1995: Scagliotti G V; Masiero P; Pozzi E
Biological prognostic factors in non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1995;12 Suppl 1():S13-25.
1994: Leonardo E; Valente G; Cappia S; Cianfriglia M; Arancia G; Meschini S; Scagliotti G V
Immunohistochemical evaluation of P-glycoprotein in human malignancies by monoclonal antibody MC57.
International journal of cancer. Journal international du cancer 1994;57(6):841-6.
1994: Cianfriglia M; Willingham M C; Tombesi M; Scagliotti G V; Frasca G; Chersi A
P-glycoprotein epitope mapping. I. Identification of a linear human-specific epitope in the fourth loop of the P-glycoprotein extracellular domain by MM4.17 murine monoclonal antibody to human multi-drug-resistant cells.
International journal of cancer. Journal international du cancer 1994;56(1):153-60.
1993: Scagliotti G V; Micela M; Gubetta L; Leonardo E; Cappia S; Borasio P; Pozzi E
Prognostic significance of Ki67 labelling in resected non small cell lung cancer.
European journal of cancer (Oxford, England : 1990) 1993;29A(3):363-5.
1992: Garbisa S; Scagliotti G; Masiero L; Di Francesco C; Caenazzo C; Onisto M; Micela M; Stetler-Stevenson W G; Liotta L A
Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy.
Cancer research 1992;52(16):4548-9.
1991: Scagliotti G V; Michelotto F; Kalikatzaros G; Leonardo E; Cappia S; Gubetta L; Borasio P; Pozzi E
Detection of multidrug resistance associated P-170 glycoprotein in previously untreated non small cell lung cancer.
Anticancer research 1991;11(6):2207-10.
1991: Ardizzoni A; Rosso R; Salvati F; Scagliotti G; Soresi E; Ferrara G; Pennucci C; Baldini E; Cruciani A R; Antilli A
Combination chemotherapy and interferon alpha 2b in the treatment of advanced non-small-cell lung cancer. The Italian Lung Cancer Task Force (FONICAP).
American journal of clinical oncology 1991;14(2):120-3.
1991: Albera C; Mabritto I; Ghio P; Scagliotti G V; Pozzi E
Lymphocyte subpopulations analysis in pleural fluid and peripheral blood in patients with lymphocytic pleural effusions.
Respiration; international review of thoracic diseases 1991;58(2):65-71.
1991: Planting A S; Ardizzoni A; Estapé J; Giaccone G; Scagliotti G; Splinter T A; Kirkpatrick A; Dalesio O; McVie J G
Phase II study of ACNU in non-small-cell lung cancer: EORTC study 08872.
Cancer chemotherapy and pharmacology 1991;28(2):145-6.
1989: Scagliotti G V; Piani M; Gatti E; Gozzelino F; Albera C; Pozzi E
Combined measurements of neuron specific enolase and bombesin/gastrin releasing peptide in lung cancer.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1989;2(8):746-50.
1989: Scagliotti G V; Gozzelino F; Albera C; Pescetti G
Chronic administration of lonidamine in untreated non-small cell lung cancer of stage III M0-1.
Chemotherapy 1989;35(1):64-8.
1986: Scagliotti G V; Bardessono F; Gozzelino F; D'Apuzzo C; Albera C; Pescetti G
Combination chemotherapy for non small cell lung cancer stage III M0-1 with cisplatin and vinblastine in a divided-dose schedule.
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy 1986;5(5):351-5.
1985: Scagliotti G V; Lodico D; Gozzelino F; Bardessono F; Albera C; Gatti E; Pescetti G
Unresectable non-small cell lung cancer chemotherapy with high-dose cisplatin and etoposide.
Oncology 1985;42(4):224-8.
1984: Scagliotti G; Lodico D; Gozzelino F; Pescetti G
Etoposide by oral route in the treatment of unresectable non-small cell lung cancer.
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy 1984;3(5):324-6.
1980: Pescetti G; Gozzelino F; Osella D; Scagliotti G
[Ultrastructure of the pulmonary alveolus. Correlations with the endoalveolar tensioactive system]
Minerva medica 1980;71(2):73-82.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Giorgio Scagliotti

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Giorgio Scagliotti (preview)

All Publications